Business Context and Reporting Period
This Form 8-K reports the results of the annual meeting of stockholders for SeaStar Medical Holding Corp, held virtually on July 3, 2025. The filing details the voting outcomes for five proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Stockholders approved the following proposals:
- Proposal 1 (Director Election): Elected Eric Schlorff and Kenneth Van Heel as Class III Directors to serve until the 2028 annual meeting.
- Proposal 2 (Equity Plan Amendment): Approved an amendment to the 2022 Omnibus Equity Incentive Plan to increase authorized shares from 570,457 to 2,070,457 (adjusted for a 1-for-25 reverse stock split) and remove the evergreen provision.
- Proposal 3 (Lincoln Park Purchase Agreement): Approved the potential future sale and issuance of common stock to Lincoln Park, allowing them to own in excess of 19.99% of outstanding shares.
- Proposal 4 (Auditor Ratification): Ratified the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proposal 5 (Adjournment): Approved a proposal to adjourn or postpone the meeting if necessary to permit further solicitation of proxies.
Guidance, Outlook, and Risks
The filing text does not provide specific management commentary, financial guidance, or a discussion of risks and contingencies beyond the approval of the Lincoln Park transaction, which involves a significant change in ownership structure.
Investor Verification Checklist
- Verify the impact of the 1-for-25 reverse stock split on the newly authorized share count of 2,070,457.
- Review the specific terms of the Lincoln Park Purchase Agreement regarding the issuance of shares exceeding the 19.99% threshold.
- Confirm the tenure and qualifications of the newly elected Class III Directors, Eric Schlorff and Kenneth Van Heel.
- Assess the implications of removing the evergreen provision from the Equity Incentive Plan on future employee compensation.